NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 139 filers reported holding NATERA INC in Q2 2019. The put-call ratio across all filers is 1.60 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $166,000 | +45.8% | 1,815 | -0.1% | 0.00% | – |
Q4 2023 | $113,817 | +43.0% | 1,817 | +1.0% | 0.00% | -100.0% |
Q3 2023 | $79,606 | -15.0% | 1,799 | -6.5% | 0.00% | 0.0% |
Q2 2023 | $93,622 | +18.8% | 1,924 | +35.6% | 0.00% | 0.0% |
Q1 2023 | $78,783 | +34.3% | 1,419 | -2.8% | 0.00% | – |
Q4 2022 | $58,648 | +1.1% | 1,460 | +10.6% | 0.00% | – |
Q3 2022 | $58,000 | +23.4% | 1,320 | +0.4% | 0.00% | – |
Q2 2022 | $47,000 | -24.2% | 1,315 | -14.4% | 0.00% | – |
Q1 2022 | $62,000 | -56.9% | 1,536 | -0.1% | 0.00% | -100.0% |
Q4 2021 | $144,000 | -18.6% | 1,537 | -3.4% | 0.00% | 0.0% |
Q3 2021 | $177,000 | -3.3% | 1,591 | -1.1% | 0.00% | 0.0% |
Q2 2021 | $183,000 | -96.1% | 1,608 | -96.5% | 0.00% | -93.8% |
Q1 2021 | $4,682,000 | +1.7% | 46,108 | -0.3% | 0.02% | -5.9% |
Q4 2020 | $4,604,000 | +50.6% | 46,259 | +9.3% | 0.02% | +13.3% |
Q3 2020 | $3,058,000 | +43.8% | 42,330 | -0.8% | 0.02% | +50.0% |
Q2 2020 | $2,127,000 | +93.0% | 42,662 | +15.6% | 0.01% | +66.7% |
Q1 2020 | $1,102,000 | -16.2% | 36,898 | -5.5% | 0.01% | +20.0% |
Q4 2019 | $1,315,000 | +13.5% | 39,029 | +10.5% | 0.01% | 0.0% |
Q3 2019 | $1,159,000 | +18.1% | 35,334 | -0.7% | 0.01% | +25.0% |
Q2 2019 | $981,000 | +123.5% | 35,579 | +67.1% | 0.00% | +100.0% |
Q1 2019 | $439,000 | +44.9% | 21,295 | -1.7% | 0.00% | +100.0% |
Q4 2018 | $303,000 | -42.1% | 21,671 | -0.8% | 0.00% | -50.0% |
Q3 2018 | $523,000 | +44.9% | 21,839 | +13.9% | 0.00% | +100.0% |
Q2 2018 | $361,000 | +91.0% | 19,182 | -6.0% | 0.00% | 0.0% |
Q1 2018 | $189,000 | -2.1% | 20,410 | -5.1% | 0.00% | 0.0% |
Q4 2017 | $193,000 | -28.8% | 21,507 | +2.2% | 0.00% | 0.0% |
Q3 2017 | $271,000 | +27.8% | 21,053 | +8.1% | 0.00% | 0.0% |
Q2 2017 | $212,000 | +49.3% | 19,478 | +21.2% | 0.00% | 0.0% |
Q1 2017 | $142,000 | -19.3% | 16,065 | +7.1% | 0.00% | 0.0% |
Q4 2016 | $176,000 | -99.9% | 14,997 | -0.3% | 0.00% | 0.0% |
Q3 2016 | $167,050,000 | -7.8% | 15,036 | +0.2% | 0.00% | 0.0% |
Q2 2016 | $181,132,000 | +212.3% | 15,013 | +147.7% | 0.00% | – |
Q1 2016 | $58,000,000 | +1833.3% | 6,062 | +1920.7% | 0.00% | – |
Q4 2015 | $3,000,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |